EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Deubiquitination of ETV4 by USP7 Promotes NSCLC Tumorigenesis via MAPK7 Activation

Xue Meng iD, Jiaxi Zhang iD, Ning Zhang, Yuqi Hou, Yimeng Li, Jia Kang, Ruxin Li, Yinghui Shi, Juan Wang, Lixin Cheng iD, Lingxiao Xing iD

Human Mutation · 2026-01 · 2026 (1)

DOI: 10.1155/humu/9432303 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Mutation, online erschienen am 06.05.2026. Verfasst von Xue Meng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Hebei Medical University, Shijiazhuang, Hebei, China, hebmu.edu.cn. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Ubiquitin-Specific Peptidase 7, Lung Neoplasms, Adenovirus E1A Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hebei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transcriptional dysregulation in cancer is accompanied by an anabolic transcriptional response driving proliferation and metabolic adaptation. We previously found that oncogenic ETS variant transcription factor 4 (ETV4) overexpression is associated with DNA replication, glycolytic metabolism, tumor progression, and poor prognosis in non–small cell lung cancer (NSCLC). ETV4 is markedly overexpressed in multiple NSCLC datasets, including TCGA‐LUAD and TCGA‐LUSC. Importantly, ETV4 expression positively correlates with ubiquitin‐specific protease 7 (USP7) and mitogen‐activated protein kinase 7 (MAPK7) levels. While the E3 ligase constitutive photomorphogenesis protein 1 (COP1) is known to regulate ETV4 ubiquitination and degradation, ETV4 deubiquitination remains unclear. Our study reveals that USP7 deubiquitinates ETV4 and protects it from K11‐ and K48‐linked ubiquitination and proteasomal degradation in NSCLC cells. ETV4 transcriptionally controls the expression of the MAPK pathway key gene MAPK7, which encodes extracellular signal‐regulated kinase 5 (ERK5), and participates in the regulation of cell proliferation. Genetic knockdown or pharmacological inhibition of USP7 affects the transcriptional activity of ETV4 on its target gene MAPK7/ERK5. USP7 inhibitor P22077 significantly attenuates ETV4‐MAPK7‐induced cell proliferation in vitro and tumor growth in vivo. Furthermore, elevated ETV4, USP7, and ERK5 protein expressions are associated with poor prognosis of NSCLC patients. These findings identify that USP7 regulates the deubiquitination, stability, and transcriptional activity of ETV4, contributing to the malignant phenotype of ETV4. Inhibition of USP7 might be a promising target in NSCLC with the dysregulation of ETV4 or hyperactivated MAPK signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungUbiquitin-Specific Peptidase 7Lung NeoplasmsAdenovirus E1A ProteinsMitogen-Activated Protein Kinase 7CarcinogenesisProto-Oncogene Proteins c-etsHumansUbiquitinationAnimalsCell Line, TumorGene Expression Regulation, NeoplasticMiceCell Proliferation

Stichwörter der Autor:innen

ERK5ETV4USP7deubiquitinationnon–small cell lung cancer

Substanzen

ETV4 protein, humanUbiquitin-Specific Peptidase 7Adenovirus E1A ProteinsUSP7 protein, humanMitogen-Activated Protein Kinase 7Proto-Oncogene Proteins c-ets

Autor:innen und Institutionen

  • Department of Pathology, Hebei Medical University, Shijiazhuang, Hebei, China, hebmu.edu.cn.
  • Center of Metabolic Diseases and Cancer Research, Institute of Medical and Health Science, Hebei Medical University, Shijiazhuang, Hebei, China, hebmu.edu.cn.
  • Department of Infectious Diseases, Shijiazhuang Fifth Hospital, Shijiazhuang, Hebei, China.
  • Department of Geriatrics, Guangdong Provincial Clinical Research Center for Geriatrics, Shenzhen People's Hospital (The First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medic…
  • Institute of Health Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China, sustc.edu.cn.
  • Department of Pathology, Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China, hebmu.edu.cn.

ORCID-Profile: Xue Meng, Jiaxi Zhang, Lixin Cheng, Lingxiao Xing

Förderung

  • Natural Science Foundation of Hebei Province

Zitieren

APA

Meng, X., Zhang, J., Zhang, N., Hou, Y., Li, Y., Kang, J., Li, R., Shi, Y., Wang, J., Cheng, L., & Xing, L. (2026). Deubiquitination of ETV4 by USP7 Promotes NSCLC Tumorigenesis via MAPK7 Activation. Human Mutation, 2026(1). https://doi.org/10.1155/humu/9432303

Vancouver

Meng X, Zhang J, Zhang N, Hou Y, Li Y, Kang J, et al. Deubiquitination of ETV4 by USP7 Promotes NSCLC Tumorigenesis via MAPK7 Activation. Human Mutation. 2026;2026(1). doi:10.1155/humu/9432303

BibTeX
@article{Meng2026,
  author = {Meng, Xue and Zhang, Jiaxi and Zhang, Ning and Hou, Yuqi and Li, Yimeng and Kang, Jia and Li, Ruxin and Shi, Yinghui and Wang, Juan and Cheng, Lixin and Xing, Lingxiao},
  title = {Deubiquitination of ETV4 by USP7 Promotes NSCLC Tumorigenesis via MAPK7 Activation},
  journal = {Human Mutation},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/humu/9432303}
}
Kostenlos starten →